» Articles » PMID: 17415797

Defining Mild Cognitive Impairment in Parkinson's Disease

Overview
Journal Mov Disord
Date 2007 Apr 7
PMID 17415797
Citations 166
Authors
Affiliations
Soon will be listed here.
Abstract

Our purpose was to characterize a state of mild cognitive impairment (MCI) in Parkinson's disease (PD) (PD-MCI) that would be analogous to the MCI that is posited as a precursor of Alzheimer's disease (AD). We categorized 86 PD subjects in a brain bank population as either cognitively normal (PD-CogNL), PD-MCI using criteria that included a 1.5 standard deviation or greater deficit upon neuropsychological testing consistently across at least one cognitive domain without dementia, and PD dementia (PD-D) using DSM-IV criteria. Twenty-one percent of our PD sample met criteria for PD-MCI, 62% were PD-CogNL, and 17% had PD-D. The mean duration of PD and MMSE scores of the PD-MCI group were intermediate and significantly different from both PD-CogNL and PD-D. The cognitive domain most frequently abnormal in PD-MCI was frontal/executive dysfunction followed by amnestic deficit. Single domain PD-MCI was more common than PD-MCI involving multiple domains. We conclude that a stage of clinical cognitive impairment in PD exists between PD-CogNL and PD-D, and it may be defined by applying criteria similar to the MCI that is posited as a precursor of AD. Defining PD-MCI offers an opportunity for further study of cognitive impairment in PD and targets for earlier therapeutic intervention.

Citing Articles

Automatically Detecting Errors and Disfluencies in Read Speech to Predict Cognitive Impairment in People with Parkinson's Disease.

Romana A, Bandon J, Perez M, Gutierrez S, Richter R, Roberts A Interspeech. 2024; 2021:1907-1911.

PMID: 39170691 PMC: 11336386. DOI: 10.21437/interspeech.2021-1694.


Disease progression in Parkinson's disease patients with mild cognitive impairment: 5-year longitudinal study from the early Parkinson's disease longitudinal Singapore (PALS) cohort.

Deng X, Saffari S, Xiao B, Ng S, Chia N, Choi X Aging (Albany NY). 2024; 16(15):11491-11500.

PMID: 39137312 PMC: 11346777. DOI: 10.18632/aging.206040.


The Contribution of Type 2 Diabetes to Parkinson's Disease Aetiology.

Ribaric S Int J Mol Sci. 2024; 25(8).

PMID: 38673943 PMC: 11050090. DOI: 10.3390/ijms25084358.


Parkinson's Disease and Dementia with Lewy Bodies: One and the Same.

Borghammer P, Okkels N, Weintraub D J Parkinsons Dis. 2024; 14(3):383-397.

PMID: 38640172 PMC: 11091584. DOI: 10.3233/JPD-240002.


White matter biomarker for predicting de novo Parkinson's disease using tract-based spatial statistics: a machine learning-based model.

Zhang Q, Wang H, Shi Y, Li W Quant Imaging Med Surg. 2024; 14(4):3086-3106.

PMID: 38617147 PMC: 11007501. DOI: 10.21037/qims-23-1478.